| - GRCh37:
- Chr12:52306249-52314687
- GRCh38:
- Chr12:51912465-51920903
| ACVRL1 | | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306271-52306272
- GRCh38:
- Chr12:51912487-51912488
| ACVRL1 | R7fs | Cardiovascular phenotype | Pathogenic (Jul 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306295
- GRCh38:
- Chr12:51912511
| ACVRL1 | L13fs | Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr12:52306298-52306299
- GRCh38:
- Chr12:51912514-51912515
| ACVRL1 | M15fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jul 3, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306306-52306307
- GRCh38:
- Chr12:51912522-51912523
| ACVRL1 | L17fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306316
- GRCh38:
- Chr12:51912532
| ACVRL1 | Q20* | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jan 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306320
- GRCh38:
- Chr12:51912536
| ACVRL1 | | not provided | Likely pathogenic (Jan 23, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306320
- GRCh38:
- Chr12:51912536
| ACVRL1 | | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306847-52306887
- GRCh38:
- Chr12:51913063-51913103
| ACVRL1 | | Cardiovascular phenotype | Likely pathogenic (Apr 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306863-52307574
- GRCh38:
- Chr12:51913079-51913790
| ACVRL1 | | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Nov 18, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306886
- GRCh38:
- Chr12:51913102
| ACVRL1 | D22fs | Cardiovascular phenotype | Pathogenic (Sep 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306887
- GRCh38:
- Chr12:51913103
| ACVRL1 | P23fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Dec 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306889-52306911
- GRCh38:
- Chr12:51913105-51913127
| ACVRL1 | V24fs | Cardiovascular phenotype | Pathogenic (Jul 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306891-52306898
- GRCh38:
- Chr12:51913107-51913114
| ACVRL1 | K25fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Sep 16, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306894
- GRCh38:
- Chr12:51913110
| ACVRL1 | K25* | Cardiovascular phenotype | Pathogenic (Apr 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306895-52306898
- GRCh38:
- Chr12:51913111-51913114
| ACVRL1 | | Cardiovascular phenotype | Pathogenic (Sep 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306899-52306902
- GRCh38:
- Chr12:51913115-51913118
| ACVRL1 | S27fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jun 27, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306904
- GRCh38:
- Chr12:51913120
| ACVRL1 | G29fs | Telangiectasia, hereditary hemorrhagic, type 2, not provided | Pathogenic (Aug 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306920-52306921
- GRCh38:
- Chr12:51913136-51913137
| ACVRL1 | C34fs | Cardiovascular phenotype | Pathogenic (Aug 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306921
- GRCh38:
- Chr12:51913137
| ACVRL1 | C34R | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306922
- GRCh38:
- Chr12:51913138
| ACVRL1 | C34Y | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Dec 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306923
- GRCh38:
- Chr12:51913139
| ACVRL1 | C34* | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jul 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306926
- GRCh38:
- Chr12:51913142
| ACVRL1 | C36fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jul 17, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306927
- GRCh38:
- Chr12:51913143
| ACVRL1 | C36R | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306935-52306936
- GRCh38:
- Chr12:51913151-51913152
| ACVRL1 | P39fs | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic (Apr 24, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306942
- GRCh38:
- Chr12:51913158
| ACVRL1 | C41G | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306943
- GRCh38:
- Chr12:51913159
| ACVRL1 | C41Y | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306946-52306947
- GRCh38:
- Chr12:51913162-51913163
| ACVRL1 | P44fs | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic (Nov 14, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306947-52306962
- GRCh38:
- Chr12:51913163-51913178
| ACVRL1 | T45fs | Cardiovascular phenotype | Pathogenic (May 13, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306947-52306960
- GRCh38:
- Chr12:51913163-51913176
| ACVRL1 | P44fs | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic (Apr 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306949-52306953
- GRCh38:
- Chr12:51913165-51913169
| ACVRL1 | G43fs | Cardiovascular phenotype | Pathogenic (Apr 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306951-52306967
- GRCh38:
- Chr12:51913167-51913183
| ACVRL1 | P44fs | Cardiovascular phenotype | Pathogenic (Dec 2, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306952-52306953
- GRCh38:
- Chr12:51913168-51913169
| ACVRL1 | C46fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Dec 7, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306953
- GRCh38:
- Chr12:51913169
| ACVRL1 | C46fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Oct 22, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306958-52306959
- GRCh38:
- Chr12:51913174-51913175
| ACVRL1 | R47fs | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic (Jan 1, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306960-52306961
- GRCh38:
- Chr12:51913176-51913177
| ACVRL1 | R47fs | not provided, Cardiovascular phenotype | Pathogenic (May 31, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306960-52306961
- GRCh38:
- Chr12:51913176-51913177
| ACVRL1 | A49fs | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype, not provided
| Pathogenic (Jan 4, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306961
- GRCh38:
- Chr12:51913177
| ACVRL1 | A49fs | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306961
- GRCh38:
- Chr12:51913177
| ACVRL1 | R47P | Cardiovascular phenotype, not provided, Telangiectasia, hereditary hemorrhagic, type 2
| Pathogenic/Likely pathogenic (Aug 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306963
- GRCh38:
- Chr12:51913179
| ACVRL1 | G48R | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306964
- GRCh38:
- Chr12:51913180
| ACVRL1 | G48E | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic/Likely pathogenic (Apr 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306964-52306968
- GRCh38:
- Chr12:51913180-51913184
| ACVRL1 | | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (May 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr12:52306969
- GRCh38:
- Chr12:51913185
| ACVRL1 | W50G | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306969
- GRCh38:
- Chr12:51913185
| ACVRL1 | W50R | Hereditary hemorrhagic telangiectasia, Telangiectasia, hereditary hemorrhagic, type 2, Telangiectasia, hereditary hemorrhagic, type 2
| Likely pathogenic (Jan 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306971
- GRCh38:
- Chr12:51913187
| ACVRL1 | W50C | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306971
- GRCh38:
- Chr12:51913187
| ACVRL1 | W50C | Cardiovascular phenotype, not provided, Telangiectasia, hereditary hemorrhagic, type 2
| Pathogenic (May 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306972
- GRCh38:
- Chr12:51913188
| ACVRL1 | C51S | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306973
- GRCh38:
- Chr12:51913189
| ACVRL1 | C51Y | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype, not provided
| Pathogenic (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52306975
- GRCh38:
- Chr12:51913191
| ACVRL1 | T52P | Cardiovascular phenotype | Likely pathogenic (Sep 26, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52306997-52306998
- GRCh38:
- Chr12:51913213-51913214
| ACVRL1 | R61fs | Cardiovascular phenotype | Pathogenic (Jul 5, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307003
- GRCh38:
- Chr12:51913219
| ACVRL1 | R61fs | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic (Aug 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307007
- GRCh38:
- Chr12:51913223
| ACVRL1 | Q64fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Oct 8, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307011
- GRCh38:
- Chr12:51913227
| ACVRL1 | Q64* | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jan 29, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307013
- GRCh38:
- Chr12:51913229
| ACVRL1 | E65fs | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Apr 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307014
- GRCh38:
- Chr12:51913230
| ACVRL1 | E65* | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307020
- GRCh38:
- Chr12:51913236
| ACVRL1 | R67G | not provided | Likely pathogenic (Sep 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307020
- GRCh38:
- Chr12:51913236
| ACVRL1 | R67W | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2, not provided, Abnormality of the pulmonary vasculature | Pathogenic/Likely pathogenic (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307021
- GRCh38:
- Chr12:51913237
| ACVRL1 | R67P | Telangiectasia, hereditary hemorrhagic, type 1 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr12:52307021
- GRCh38:
- Chr12:51913237
| ACVRL1 | R67Q | not provided, Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype
| Pathogenic/Likely pathogenic (Nov 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307026
- GRCh38:
- Chr12:51913242
| ACVRL1 | C69R | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jul 13, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307027
- GRCh38:
- Chr12:51913243
| ACVRL1 | C69Y | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307027
- GRCh38:
- Chr12:51913243
| ACVRL1 | C69F | not provided, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic/Likely pathogenic (Jun 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307028
- GRCh38:
- Chr12:51913244
| ACVRL1 | C69* | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic (Sep 30, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307031-52307034
- GRCh38:
- Chr12:51913247-51913250
| ACVRL1 | L72fs | Cardiovascular phenotype | Pathogenic (Jan 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307042
- GRCh38:
- Chr12:51913258
| ACVRL1 | E75fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307044
- GRCh38:
- Chr12:51913260
| ACVRL1 | E75* | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jun 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307050
- GRCh38:
- Chr12:51913266
| ACVRL1 | C77R | Cardiovascular phenotype | Likely pathogenic (Sep 26, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307052
- GRCh38:
- Chr12:51913268
| ACVRL1 | C77W | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307053-52307054
- GRCh38:
- Chr12:51913269-51913270
| ACVRL1 | R80fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Dec 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307054
- GRCh38:
- Chr12:51913270
| ACVRL1 | R80fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jan 3, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307056
- GRCh38:
- Chr12:51913272
| ACVRL1 | G79R | Cardiovascular phenotype | Likely pathogenic (Mar 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307057
- GRCh38:
- Chr12:51913273
| ACVRL1 | G79E | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Aug 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307060-52307061
- GRCh38:
- Chr12:51913276-51913277
| ACVRL1 | T82fs | Cardiovascular phenotype | Pathogenic (Oct 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307079
- GRCh38:
- Chr12:51913295
| ACVRL1 | H87fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Jan 1, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307085
- GRCh38:
- Chr12:51913301
| ACVRL1 | Y88* | not provided | Pathogenic (Aug 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307086
- GRCh38:
- Chr12:51913302
| ACVRL1 | C89G | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307086
- GRCh38:
- Chr12:51913302
| ACVRL1 | C89R | Cardiovascular phenotype, not specified, Telangiectasia, hereditary hemorrhagic, type 2
| Pathogenic/Likely pathogenic (Dec 6, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307087
- GRCh38:
- Chr12:51913303
| ACVRL1 | C89F | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307088
- GRCh38:
- Chr12:51913304
| ACVRL1 | C89W | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307090
- GRCh38:
- Chr12:51913306
| ACVRL1 | C90F | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype | Pathogenic/Likely pathogenic (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307090
- GRCh38:
- Chr12:51913306
| ACVRL1 | C90Y | Telangiectasia, hereditary hemorrhagic, type 2, Cardiovascular phenotype, not provided
| Pathogenic/Likely pathogenic (Aug 14, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307091
- GRCh38:
- Chr12:51913307
| ACVRL1 | C90W | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic/Likely pathogenic (Jul 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307091
- GRCh38:
- Chr12:51913307
| ACVRL1 | C90* | Cardiovascular phenotype, Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic/Likely pathogenic (Apr 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr12:52307092
- GRCh38:
- Chr12:51913308
| ACVRL1 | D91fs | not specified | Pathogenic (Sep 20, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307107
- GRCh38:
- Chr12:51913323
| ACVRL1 | N96D | Telangiectasia, hereditary hemorrhagic, type 2 | Likely pathogenic (Oct 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307108
- GRCh38:
- Chr12:51913324
| ACVRL1 | N96S | Cardiovascular phenotype | Likely pathogenic (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307115-52307119
- GRCh38:
- Chr12:51913331-51913335
| ACVRL1 | V99fs | not provided | Pathogenic (Mar 21, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307123
- GRCh38:
- Chr12:51913339
| ACVRL1 | L101fs | not provided | Likely pathogenic (Dec 13, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307131
- GRCh38:
- Chr12:51913347
| ACVRL1 | E104* | Cardiovascular phenotype | Pathogenic (Mar 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307133-52307134
- GRCh38:
- Chr12:51913349-51913350
| ACVRL1 | | Cardiovascular phenotype | Likely pathogenic (May 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307135
- GRCh38:
- Chr12:51913351
| ACVRL1 | | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307135
- GRCh38:
- Chr12:51913351
| ACVRL1 | | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Dec 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307136
- GRCh38:
- Chr12:51913352
| ACVRL1 | | Cardiovascular phenotype | Likely pathogenic (Nov 18, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307323-52312919
- GRCh38:
- Chr12:51913539-51919135
| ACVRL1 | | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Apr 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307358
- GRCh38:
- Chr12:51913574
| ACVRL1 | S110* | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Aug 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307363
- GRCh38:
- Chr12:51913579
| ACVRL1 | Q112* | Cardiovascular phenotype | Pathogenic (May 11, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307365
- GRCh38:
- Chr12:51913581
| ACVRL1 | Q112fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Sep 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307376-52307377
- GRCh38:
- Chr12:51913592-51913593
| ACVRL1 | L121fs | Cardiovascular phenotype | Pathogenic (May 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307381
- GRCh38:
- Chr12:51913597
| ACVRL1 | Q118* | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Nov 27, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr12:52307386-52307398
- GRCh38:
- Chr12:51913602-51913614
| ACVRL1 | L121fs | Telangiectasia, hereditary hemorrhagic, type 2 | Pathogenic (Mar 9, 2020) | criteria provided, single submitter |